Association of inflammatory markers with depression and anxiety in female patients with primary Sjögren's syndrome
- PMID: 40822847
- PMCID: PMC12334945
- DOI: 10.11613/BM.2025.030701
Association of inflammatory markers with depression and anxiety in female patients with primary Sjögren's syndrome
Abstract
Introduction: Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease affecting exocrine glands and is frequently accompanied by depression and anxiety. Proinflammatory cytokines, particularly interleukin 6 (IL-6), have been implicated in the pathogenesis of both pSS and mood disorders. This study aimed to assess the association between inflammatory markers, disease activity, and psychological symptoms in patients with pSS.
Materials and methods: A cross-sectional study was conducted on 60 female patients diagnosed with pSS at Sestre milosrdnice University Hospital Center between 2019 and 2021. Depression and anxiety were evaluated using the Hospital Anxiety and Depression Scale. Inflammatory biomarkers (erythrocyte sedimentation rate, rheumatoid factor, ferritin, fibrinogen, CRP, C3, C4, IL-6) and disease activity indices (ESSDAI, ESSPRI) were analyzed. Statistical analyses, including logistic regression, were applied to determine independent predictors of depression and anxiety.
Results: Depression was detected in 39/60 of patients, while 34/60 exhibited anxiety symptoms. Patients with either depression or anxiety had significantly higher IL-6 concentration (P < 0.001 and P = 0.002, respectively). Logistic regression identified IL-6 as an independent predictor of depression (OR = 3.23, 95%CI: 1.07 - 9.80, P = 0.038), while ESSPRI fatigue was a significant predictor of anxiety (OR = 2.01, 95%CI: 1.13 - 3.58, P = 0.018).
Conclusions: The findings suggest that IL-6 could be a predictor of pSS-related depression, potentially serving as a biomarker for this extraglandular manifestation and ESSPRI fatigue as a predictor for anxiety.
Keywords: anxiety; depression; inflammation; interleukin 6; primary Sjögren’s syndrome.
Croatian Society of Medical Biochemistry and Laboratory Medicine.
Conflict of interest statement
Potential conflict of interest None declared.
Figures
Similar articles
-
Association of the energy-adjusted dietary inflammatory index and Sjögren's syndrome: a cross-sectional study.Br J Nutr. 2025 Jun 14;133(11):1422-1430. doi: 10.1017/S0007114525103474. Epub 2025 Jun 3. Br J Nutr. 2025. PMID: 40458010 Free PMC article.
-
Gynecological symptoms in primary and secondary Sjögren's syndrome and the effect of the disease on sexuality.J Sex Med. 2024 Feb 27;21(3):248-254. doi: 10.1093/jsxmed/qdae004. J Sex Med. 2024. PMID: 38366657
-
A retrospective study of electrocardiographic alterations in primary Sjögren's syndrome: role of anti-SSA positivity and disease duration.Clin Rheumatol. 2025 Jun;44(6):2377-2386. doi: 10.1007/s10067-025-07477-x. Epub 2025 May 10. Clin Rheumatol. 2025. PMID: 40346441
-
Expression of interleukin-17 in primary Sjögren's syndrome and the correlation with disease severity: A systematic review and meta-analysis.Scand J Immunol. 2018 Apr;87(4):e12649. doi: 10.1111/sji.12649. Scand J Immunol. 2018. PMID: 29476557
-
A systematic review of primary Sjögren's syndrome in male and paediatric populations.Clin Rheumatol. 2017 Oct;36(10):2225-2236. doi: 10.1007/s10067-017-3745-z. Epub 2017 Jul 22. Clin Rheumatol. 2017. PMID: 28735431 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous